Edith Charlier
Impact in
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Peroxisome Proliferator-Activated Receptors 1
- Ubiquitin and proteasome pathways 1
-
- Osteoarthritis Treatment and Mechanisms 6
- Co-authors
- Michel Malaise (13 shared papers)Dominique de Seny (14 shared papers)Sophie Neuville (12 shared papers)Céline Deroyer (9 shared papers)Olivier Malaise (7 shared papers)Biserka Relić (8 shared papers)Federica Ciregia (2 shared papers)Zelda Plener (3 shared papers)
- Journals
- Biochemical Pharmacology (3 papers)Oncotarget (2 papers)PLoS ONE (2 papers)Lara D. Veeken (2 papers)Arthritis Research & Therapy (1 paper)
- Partner nations
- BelgiumUnited StatesSpain
In The Last Decade
Edith Charlier
15 papers receiving 917 citations
Edith Charlier's Hit Papers
Peers
Comparison fields: 5 of 78
- Rheumatology 535
- Cancer Research 173
- Immunology and Allergy 53
- Pharmacology 122
- Urology 37
Countries citing papers authored by Edith Charlier
This map shows the geographic impact of Edith Charlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Charlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Charlier more than expected).
Fields of papers citing papers by Edith Charlier
This network shows the impact of papers produced by Edith Charlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Charlier. The network helps show where Edith Charlier may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith Charlier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chondrocyte dedifferentiation and osteoarthritis (OA) Hit paper breakdown → | 2019 | 349 |
| 2 | 2016 | 276 | |
| 3 | 2013 | 69 | |
| 4 | 2019 | 68 | |
| 5 | 2015 | 42 | |
| 6 | 2019 | 34 | |
| 7 | 2011 | 14 | |
| 8 | 2008 | 14 | |
| 9 | 2016 | 14 | |
| 10 | 2014 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2020 | 7 | |
| 13 | 2016 | 7 | |
| 14 | 2018 | 5 | |
| 15 | 2025 | 1 |
About Edith Charlier
Edith Charlier is a scholar working on Molecular Biology, Rheumatology, Epidemiology, Cell Biology and Pharmacology, having authored 15 papers that have together received 926 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Inflammatory mediators and NSAID effects (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Autophagy in Disease and Therapy (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Toxoplasma gondii Research Studies (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Rheumatology (535 citations), Cancer Research (173 citations), Immunology and Allergy (53 citations), Pharmacology (122 citations) and Urology (37 citations). Edith Charlier has collaborated with scholars based in Belgium, United States and Spain. Frequent co-authors include Michel Malaise, Dominique de Seny, Sophie Neuville, Céline Deroyer, Olivier Malaise, Biserka Relić, Federica Ciregia, Zelda Plener, Julie Collée and Olivier Malaise. Their work appears in journals such as Biochemical Pharmacology, Oncotarget, PLoS ONE, Lara D. Veeken and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.